An analysis of medication adherence and birth outcomes among members receiving progesterone for the prevention of preterm birth in a state Medicaid program.
The ninth edition of Common Health for the Commonwealth updates data and trends on preventable health conditions and social factors affecting the health of Massachusetts residents. The report covers Social Determinants of Health, Health Risk Factors, and Preventable Health Conditions.
As President Donald J. Trump begins his term and his administration takes shape, it is important for us to reflect on all of the criminal justice reforms of the past eight years under President Barack Obama. A blog on The Huffington Post outlining those reforms from Julie White of the Health and Criminal Justice Program.
An overview of Medication Therapy Management (MTM) and the Star Rating measure. Learn the best practices for a successful MTM program, including the link to Comprehensive Medication Review quality and care management team integration.
Nationwide, 65 percent of inmates meet the medical criteria for substance use disorder, but just 11 percent receive treatment while incarcerated. A UMass Medical School correctional health collaborative will address substance use disorder by assessing current screening and treatment practices for opioid addiction, making recommendations and implementing proven practicel. Warren J. Ferguson, MD, writes about the collaborative in CommonWealth magazine.
This issue brief describes the key elements of the most recent MassHealth 1115 waiver extension, including the shift to a delivery system centered on Accountable Care Organizations and Community Partners, a Delivery System Reform Incentive Program, the redesigned Safety Net Care Pool, and the expansion of services for treatment of substance use disorders. It concludes with a discussion of implications of the new system for major stakeholder groups.
How managed care organizations can better address the opioid addiction crisis, including improving access to naloxone and Medication Assisted Therapies (MAT) as well as ensuring benefit design will support alternative pain management methods.
The strategies used by the Southern New England Practice Transformation Network (SNE-PTN), a collaborative led by UMass Medical School and UConn Health, to enroll more than 5,000 clinicians from a variety of specialties by the end of October 2016. The strategies led SNE-PTN to achieve 186 percent of the year one enrollment target.
The Academy of Managed Care Pharmacy (AMCP) Partnership Forum, Navigating Innovations in Diabetes Care, brought together AMCP members, industry experts, and other key healthcare stakeholders together to discuss the impact of advances in diabetes treatments related to a range of new drugs, technology solutions and care management models.
Pipeline Trends is produced by the Clinical Pharmacy Services division and is distributed at least once a year. It provides an overview of promising new agents, investigational indications, projected generic entry, FDA updates and industry trends.
Lean about the concept of self-direction in Managed Long-Term Services and Supports, including its origin and characteristics and individual and caregiver perspectives. Also presented are health plan considerations, suggestions, and best practices.
Hospitals face financial challenges when providing access to medical interpreters. A new study shows that access to interpreters lowers readmission rates, a key quality indicator. Greater access to medical interpreters may help hospitals facing new payment incentives to reduce readmissions.
A summary of efficacy data for high-impact specialty pipeline drugs expected to reach the market, including their place in therapy and budgetary impact. Also featured are strategies to mitigate costs of these cutting-edge medications and compare them to current therapy options.
An overview of waivers made possible by Section 1115 of the Social Security Act and Section 1332 of the Affordable Care Act. It explains spending and waiver authority and the legal considerations that may arise, the ways that states have used waiver authority, and reviews the limitations and new responsibilities that come with waivers.
UMass Medical School health policy experts have developed sustainable financing models for the state of Maine to support four community health worker (CHW) interventions that focus on patients with the greatest, and most costly, health care needs.
The steps to developing Complex Care Management Model Design for state Medicaid programs with a focus on one single point of entry.
Learn the strategies required to deliver patient-centric, quality care for individuals with complex care needs. Successful coordination and management requires networking with multiple care providers and linking each intervention to the individual’s overall care.
Even with health insurance gains, access may still be an issue. State Innovation Waivers offer an opportunity to build on the Affordable Care Act and increase health insurance affordability. States can ask the federal government for authority to change parts of the ACA to achieve their goals.
A comprehensive overview of why policymakers should include language access elements in Medicaid ACO design and a description of how such a design can be implemented. Access to language services is crucial to providing quality care and reducing health disparities among patients who are deaf or Limited English Proficient.
The Care Transformation Collaborative of Rhode Island (CTC), a patient-centered medical home initiative managed by UMass Medical School, explains how primary care practices can build a medical neighborhood by creating a community health team to provide behavioral health and social support services to patients with high-cost, complex care needs.
Breakthrough direct-acting antivirals set a new standard in the management of hepatitis C virus (HCV) with regard to cure rates and improved tolerability, but cost is a challenge. We designed and implemented a comprehensive HCV medication management program that helped one state Medicaid program avoid nearly $3.8 million in costs while ensuring members have access to clinically appropriate regimens.